Patient with Creutzfeldt-Jakob Disease to Receive Experimental Treatment

October 9, 2018

(UPI) – For the first time, a patient with the rare, fatal brain disease Creutzfeldt-Jakob will be given an antibody compound developed in London. Researchers at University College London have created PRN100 for treating the disease, which currently has no cure, according to an announcement Tuesday.

Recommended Reading